OLODUO

Country: Indoneżja

Lingwa: Indoneżjan

Sors: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Ingredjent attiv:

ROSUVASTATIN CALCIUM, OLMESARTAN MEDOXOMIL

Disponibbli minn:

DAEWOONG INFION - Indonesia

INN (Isem Internazzjonali):

ROSUVASTATIN CALCIUM, OLMESARTAN MEDOXOMIL

Dożaġġ:

10.40 Mg /20.00 MG

Għamla farmaċewtika:

TABLET SALUT SELAPUT

Unitajiet fil-pakkett:

DUS, 3 BLISTER @ 10 TABLET SALUT SELAPUT

Manifatturat minn:

DAEWOONG PHARMACEUTICAL CO.,LTD - Republic Of Korea

Data ta 'l-awtorizzazzjoni:

2019-09-28

Karatteristiċi tal-prodott

OLODUO FILM-COATED TABLET
(Olmesartan medoxomil, Rosuvastatin Calcium)
COMPOSITION
Each tablet of Oloduo film-coated tablet 40/20 mg contains
Olmesartan medoxomil
‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥
40.0 mg
Rosuvastatin calcium
‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥
20.80 mg
(As Rosuvastatin 20 mg)
Each tablet of Oloduo film-coated tablet 20/10 mg contains
Olmesartan medoxomil
‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥
20.0 mg
Rosuvastatin calcium
‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥‥
10.40 mg
(As Rosuvastatin 10 mg)
DESCRIPTION
White to light yellow film-coated tablet
INDICATIONS & USAGE
Patients receiving olmesartan and rosuvastatin from separate
tablets may
receive Oloduo containing the same component doses.
This drug should not be used as initial therapy.

Olmesartan medoxomil
Treatment of essential hypertension

Rosuvastatin
-
Rosuvastatin
is
indicated
for
patients
with
primary
hypercholesteroleaemia
(type
IIa,
including
heterozygous
familial
hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct
to diet when response to diet and exercise is inadequate.
-
Rosuvastatin
reduces
elevated
LDL-cholesterol,
total
cholesterol,
triglycerides and ApoB, and increases HDL-cholesterol
DOSAGE & ADMINISTRATION
This drug should be administered to adults
Usual adult dose
Treatment should not be initiated with this combination
The recommended dosage of Oloduo is one tablet daily.
General considerations
Olmesartan/rosuvastatin
is
a
combination
product
targeting
concomitant
cardiovascular conditions hypertension and dyslipidemia.
The dosage range for olmesartan/rosuvastatin is 20 mg/10 mg to a
maximum
dose of 40 mg/20 mg once daily. Before treatment, the patient should
be
placed on a standard cholesterol lowering diet that should continue
during
treatment.
As a component of multip